David D’Cruz

18.2k total citations · 2 hit papers
279 papers, 10.8k citations indexed

About

David D’Cruz is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David D’Cruz has authored 279 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Rheumatology, 66 papers in Immunology and 60 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David D’Cruz's work include Systemic Lupus Erythematosus Research (158 papers), Vasculitis and related conditions (49 papers) and Systemic Sclerosis and Related Diseases (33 papers). David D’Cruz is often cited by papers focused on Systemic Lupus Erythematosus Research (158 papers), Vasculitis and related conditions (49 papers) and Systemic Sclerosis and Related Diseases (33 papers). David D’Cruz collaborates with scholars based in United Kingdom, United States and Canada. David D’Cruz's co-authors include Munther A. Khamashta, Graham R.V. Hughes, Shirish Sangle, David Isenberg, Caroline Gordon, Pamela Lutalo, Ian N Bruce, Jennifer Hannah, Christos Lampropoulos and Anisur Rahman and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

David D’Cruz

265 papers receiving 10.5k citations

Hit Papers

Human CD14dim Monocytes P... 2007 2026 2013 2019 2010 2007 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David D’Cruz 6.5k 4.0k 1.7k 1.6k 1.2k 279 10.8k
Graciela S. Alarcón 8.8k 1.3× 3.9k 1.0× 1.2k 0.7× 746 0.5× 1.8k 1.4× 320 12.5k
Martin Aringer 4.1k 0.6× 3.0k 0.7× 903 0.5× 1.3k 0.8× 991 0.8× 232 7.5k
Eloísa Bonfá 5.8k 0.9× 3.6k 0.9× 1.3k 0.8× 529 0.3× 1.3k 1.0× 426 10.3k
Zahir Amoura 7.3k 1.1× 6.3k 1.6× 1.3k 0.8× 3.2k 2.0× 1.8k 1.4× 424 17.6k
Earl D. Silverman 6.5k 1.0× 3.3k 0.8× 1.1k 0.7× 1.4k 0.8× 930 0.8× 258 12.1k
Gunnar Sturfelt 5.1k 0.8× 4.7k 1.2× 1.3k 0.8× 782 0.5× 810 0.7× 165 8.3k
E. William St. Clair 9.1k 1.4× 5.3k 1.3× 1.8k 1.1× 3.0k 1.8× 1.7k 1.4× 170 16.5k
Stefano Bombardieri 6.4k 1.0× 5.1k 1.3× 1.3k 0.8× 1.5k 0.9× 2.8k 2.2× 448 16.2k
D Alarcón-Segovia 7.3k 1.1× 4.4k 1.1× 2.2k 1.3× 940 0.6× 2.0k 1.6× 342 12.3k
Manuel Ramos‐Casals 7.8k 1.2× 4.2k 1.0× 1.3k 0.7× 2.0k 1.2× 2.1k 1.7× 258 18.2k

Countries citing papers authored by David D’Cruz

Since Specialization
Citations

This map shows the geographic impact of David D’Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D’Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D’Cruz more than expected).

Fields of papers citing papers by David D’Cruz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D’Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D’Cruz. The network helps show where David D’Cruz may publish in the future.

Co-authorship network of co-authors of David D’Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of David D’Cruz. A scholar is included among the top collaborators of David D’Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D’Cruz. David D’Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nanzer, Alexandra M., Linda K. Green, Louise Thomson, et al.. (2024). Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 12(3). 724–732. 13 indexed citations
2.
Mahmoud, Khaled, Md Yuzaiful Md Yusof, Lee Suan Teh, et al.. (2024). Improving the arthritis component of the SLEDAI-2K. Lara D. Veeken. 64(6). 3556–3562. 1 indexed citations
3.
Sloan, Melanie, Thomas Pollak, Efthalia Massou, et al.. (2024). Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project. Lara D. Veeken. 64(3). 1179–1192. 4 indexed citations
4.
D’Cruz, David, et al.. (2023). Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data. Lupus Science & Medicine. 10(1). e000830–e000830. 3 indexed citations
6.
Kim, Sangmi, Lena Boehme, Louise Nel, et al.. (2022). Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhances Follicular Th Cell–like Differentiation in Patients with Granulomatosis with Polyangiitis. The Journal of Immunology. 208(4). 807–818. 8 indexed citations
7.
Siu, Jacqueline H. Y., Michael J. Pitcher, Thomas J Tull, et al.. (2022). Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood. Science Immunology. 7(69). eabm9060–eabm9060. 39 indexed citations
9.
Arya, Ved Bhushan, Zita Reisz, Bassel Zebian, et al.. (2020). IgG4-related hypophysitis in adolescence. Journal of Pediatric Endocrinology and Metabolism. 34(3). 395–399. 4 indexed citations
10.
Sloan, Melanie, David D’Cruz, Felix Naughton, et al.. (2020). ‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum. Rheumatology International. 41(4). 721–732. 21 indexed citations
11.
Tull, Thomas J, Andrew Pink, Emma Benton, & David D’Cruz. (2015). Cutaneous lupus erythematosus. British Journal of Hospital Medicine. 76(11). C162–C165. 3 indexed citations
12.
Ramos‐Casals, Manuel, M J Cuadrado, Paula Alba, et al.. (2009). Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosus.. PubMed. 100(6). 437–46. 5 indexed citations
13.
Merrill, JT, Rubén Burgos‐Vargas, René Westhovens, et al.. (2008). The Efficacy and Safety of Abatacept in SLE: Results of a 12-month Exploratory Study. Queensland's institutional digital repository (The University of Queensland). 58(12). 4031–4032. 15 indexed citations
14.
D’Cruz, David, et al.. (2006). Acute manifestations of autoimmune connective tissue diseases. British Journal of Hospital Medicine. 67(5). 244–249. 1 indexed citations
15.
Adamson, Rosemary, Curtis Rambaran, & David D’Cruz. (2005). Anabolic steroid-induced rhabdomyolysis. British Journal of Hospital Medicine. 66(6). 362–362. 13 indexed citations
16.
Bennett, Alexander N., et al.. (2004). Paediatric rheumatology [271-278]. Lara D. Veeken. 43(suppl 2). ii111–ii114.
17.
Oyama, Noritaka, Ien Chan, S. M. Neill, et al.. (2004). Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Journal of Clinical Investigation. 113(11). 1550–1559. 35 indexed citations
18.
Ferro, Michela, Mohammed Yousuf Karim, I C Abbs, et al.. (2003). Mycophenolate mofetil: A potential treatment for reducing proteinuria associated with membranous lupus nephritis.. Research Portal (King's College London). 48(9). 3 indexed citations
19.
Sangle, Shirish, et al.. (2003). Prevalence of hypertension in 600 patients with antiphospholipid syndrome.. Research Portal (King's College London). 48(9). 2 indexed citations
20.
D’Cruz, David, Elaine Baguley, Ronald A. Asherson, & Graham R.V. Hughes. (1989). Ear, nose, and throat symptoms in subacute Wegener's granulomatosis.. BMJ. 299(6696). 419–422. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026